Orbsen Therapeutics orbsentherapeutics.com


Public lists: Pharma Startups (4732)

Orbsen Therapeutics, fka Pro-Cure Laboratories, is a regenerative medicine company that is developing stromal cell treatments to address a wide range of medical conditions including heart disease, arterial disease of the limbs, diabetes complications, arthritis, and other inflammatory conditions. The treatment potential is linked to the cells' natural capacity to dampen inflammation and promote healing, repair, and regeneration of damaged tissues.

Orbsen Therapeutics, fka Pro-Cure Laboratories, is a regenerative medicine company that is developing stromal cell treatments to address a wide range of medical conditions including heart disease, arterial disease of the limbs, diabetes complications...Show all

Company (Alive / Active)

Phone: +353 (0) 91 528778

Fax:

Orbsen Building, NUIG
University Road
Galway, H91 DK59
Ireland

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Orbsen Therapeutics $1.3M Jul 26, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Orbsen Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Stromal stem cells Apr 01, 2016 Application
Modulators of syndecan-2 and uses thereof Mar 18, 2016 Application
Medical use of syndecan-2 Apr 16, 2014 Application
Stromal stem cells Feb 11, 2013 Application